ResMed Executive Plans Sale of Shares
Company Announcements

ResMed Executive Plans Sale of Shares

Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD) has released an update.

ResMed Inc has notified the SEC of a proposed sale of common shares by officer and director Michael J. Farrell through Fidelity Brokerage Services. A total of 14,683 shares are expected to be sold with an aggregate market value of $3,405,206.33, following Farrell’s previous sales in the past three months totaling over $5.9 million.

For further insights into AU:RMD stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Australian Auto-Generated NewsdeskResMed Inc Director Adjusts Stock Holdings
TipRanks Australian Auto-Generated NewsdeskResMed’s Executive Stock Transactions Highlight Compensation Practices
TipRanks Australian Auto-Generated NewsdeskResMed Inc. CEO Executes Strategic Stock Transactions
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App